The effect of antibiotic therapy on nasopharyngeal colonization by Streptococcus pneumoniae and Haemophilus influenzae was evaluated in children diagnosed with acute otitis media. Children were randomly assigned to receive either amoxicillin/clavulanate or azithromycin therapy, and nasopharyngeal swabs were obtained for culture before and after starting therapy. Amoxicillin/clavulanate therapy eradicated or suppressed all strains of S. pneumoniae susceptible to penicillin, 75% of strains with intermediate resistance, and 40% of strains resistant to penicillin. Azithromycin therapy cleared two-thirds of azithromycin-susceptible strains of S. pneumoniae but none of azithromycin-nonsusceptible strains. Selection for antibiotic-resistant strains in individual children was not observed in children who received amoxicillin/clavulanate therapy but was observed in 2 children who received azithromycin therapy. Carriage of H. influenzae was also reduced by antimicrobial therapy but more so by amoxicillin/clavulanate. Antibiotic therapy does not directly increase the number of resistant strains in the population but, by eradicating susceptible strains, allows greater opportunity for carriage and spread of resistant strains.
fluids from children with AOM, especially those who have received repeated courses of antibiotics [6, 7] . The diagnostic usefulness of nasopharyngeal cultures in predicting the pathogens of AOM is limited [8, 9] ; however, these cultures do provide a reliable method to monitor the changes in antibiotic resistance of S. pneumoniae and H. influenzae in different populations [10] .
Recent studies have shown a correlation between antibiotic use and colonization by resistant pneumococcal strains [11, 12] . We sought to evaluate the effect of antibiotic therapy on nasopharyngeal colonization by S. pneumoniae and H. influenzae and to ascertain possible mechanisms responsible for emergence of resistance in S. pneumoniae. To this end, we also investigated the genetic relatedness of pneumococci isolated from the nasopharynx before and after antibiotic therapy.
Materials and Methods
Study population. From December 1997 through September 1998, children in a private suburban pediatric practice in Plano, Texas who were diagnosed to have AOM were randomized to receive either amoxicillin/clavulanate (Augmentin; SmithKline Beecham, Philadelphia), 45mg/kg/day in 2 divided doses for 10 days, or azithromycin (Zithromax; Pfizer, Groton, CT), 10 mg/kg once on the first day followed by 5 mg/kg daily for 4 days. The diagnosis of AOM was made by the attending physician according to usual clinical practice.
Boys or girls of all races aged 6 months to 6 years were eligible for the study, if their physician determined that they had AOM and that antibiotic therapy was indicated. Children were excluded from the study if they had any underlying illness, including im-munocompromising conditions, facial or palatal abnormalities predisposing to AOM, or allergy to the study antibiotics. The following information was recorded from office chart records at the time of enrollment for each child: age, sex, weight, number of siblings, hours of day care attendance per week, presence of any underlying illness, and history of otitis media and of antibiotic therapy in the previous 6 months. Children were assigned to one of the treatment groups according to a computer-generated randomization list.
Nasopharyngeal swabs (calcium alginate, cotton-tipped) were obtained before initiating therapy and again at 2 weeks and 2 months after starting therapy. At the 2-week follow-up, the clinical response to therapy was documented. At the 2-month follow-up visit, the use of any additional antibiotic therapy since completing study therapy was recorded. No systematic assessment of compliance was made.
Bacteriology. Nasopharyngeal swabs were kept moist in nutrient broth and stored at 4ЊC until they were plated (after р12 h) onto trypticase soy agar with 5% sheep blood and chocolate agar. In an effort to distinguish coresiding penicillin-susceptible and penicillin-nonsusceptible strains, we used 2 sets of blood agar plates, one containing penicillin, 0.1 mg/mL, and the other not. All blood agar plates contained 1 mg/mL gentamicin to diminish growth of gram-negative commensals. Plates were incubated in a 5% CO 2 environment at 37ЊC for 24 h and were reincubated for an additional 24 h if no growth had occurred. Any a-hemolytic colonies that grew on blood agar containing 0.1 mg/mL penicillin were spread on plates with 1 and 2 mg/mL penicillin to separate pneumococcal strains with different penicillin MICs. Four a-hemolytic colonies (unless there were fewer) were tested for each patient. Pneumococci were distinguished from other a-hemolytic streptococci on the basis of colony morphology, optochin (ethylhydrocupreine; Difco, Detroit) inhibition [13] , and bile solubility (bactidrop, 10% sodium desoxycholate; Difco).
Susceptibility to penicillin, cefotaxime, and azithromycin was determined by the epsilometric test (Etest; AB Biodisk, Solna, Sweden) [14] . Colonies were diluted in PBS to match a 0.5 McFarland standard. The bacterial suspension was spread on Mueller-Hinton blood agar plates. After placement of penicillin and cefotaxime Etest strips, plates were incubated overnight in 5% CO 2 . Azithromycin Etest strips were placed on separate plates and incubated in ambient air. The definitions for antimicrobial susceptibility to penicillin, cefotaxime, and azithromycin were based on current National Committee for Clinical Laboratory Standards guidelines [15] .
S. pneumoniae isolates were classified as follows: penicillin-susceptible, MIC р0.06 mg/mL; intermediately resistant to penicillin, MIC of 0.094-1.0 mg/mL; penicillin-resistant, MIC 11.0 mg/mL; azithromycin-susceptible, MIC !0.5 mg/mL; azithromycin-resistant, MIC 11.0 mg/mL. The class penicillin-nonsusceptible includes both strains with intermediate resistance and penicillin-resistant strains. These definitions have been modified from National Committee for Clinical Laboratory Standards guidelines [15] to include values that appear on Etest strips that fall between those defined for microdilution methods.
H. influenzae strains were identified by growth of characteristic colonies on chocolate agar and absence of growth on blood agar. The strains were confirmed by growth on quadrant plates in the presence of factors X and V. b-lactamase-producing strains were detected with a chromogenic cephalosporin (Nitrocefin; Difco).
Serogroups and serotypes of S. pneumoniae isolates were determined by Neufeld's (quellung) reaction with Danish pooled pneumococcal antisera (80 serotypes) and individual serotype-specific pneumococcal antisera (6A, 6B, 19F, 23F).
Strain-specific genomic DNA patterns were determined by use of the ERIC 1R/ERIC 2 (enterobacterial repetitive intergenic consensus) PCR primer sets. The ERIC sequence is 126 bp long. ERIC is a family of highly conserved repetitive DNA nucleotide sequences whose locations differ between species. Direct PCR amplification of bacterial DNA followed by agarose gel electrophoresis of the PCR product enables clear distinction between different bacterial species and strains [16] . In addition, the penicillin-binding protein (PBP) genotype profile of pneumococcal nasopharyngeal isolates was determined by use of PCR analysis and restriction fragment length polymorphism analysis for the 1A, 2B, and 2X binding sites. Chromosomal DNA was extracted by means of a DNA extraction kit (Quantum Biotechnologies, Montreal) [17] . PBP 1A, 2X, and 2B genes were amplified from chromosomal DNA as described previously [18, 19] . The amplified DNA products were digested by the restriction endonuclease HinfI (Roche Diagnostics, Nutley, NJ) and separated by gel electrophoresis. Gels were photographed with a Kodak Digital Science 120 system (Life Technologies Gibco BRL, Gaithersburg, MD) and the DNA patterns were analyzed [20] .
Strains were considered to be identical if there was no change in penicillin, cefotaxime, or azithromycin MIC; no change in serotype; no change in the repetitive PCR pattern; and no change in the PBP pattern other than 1 band difference at the PBP 1A gene.
For calculation of adequate sample size, pneumococcal colonization was assumed to be 40% (a value, .05; b value, .2). To show a difference of 25% in overall carriage rates after therapy between the 2 treatment arms, 60 children needed to be enrolled in each treatment arm. Categorical data were compared with the McNemar's or x 2 test and continuous data with the Student's t test.
Results
One hundred fifty-seven children, aged 6-72 months, were enrolled in this study; of these, 25 missed one or both followup visits. Only the 132 children (84%) who had specimens taken at all 3 visits are reported here; 64 received amoxicillin/clavulanate and 68 received azithromycin.
The baseline characteristics of the treatment groups were similar (table 1) . Having a sibling was associated with carriage of penicillin-nonsusceptible S. pneumoniae (x 2 test; ), but P ! .001 there was no association between the carriage of S. pneumoniae or penicillin-nonsusceptible S. pneumoniae and other potential predisposing factors, including age, day care attendance, and prior antibiotic exposure (table 2) .
At enrollment, 48% of children were carriers of S. pneumoniae and 29% were carriers of H. influenzae. The incidence of penicillin-nonsusceptible S. pneumoniae and b-lactamase-producing H. influenzae was 56% and 41%, respectively. Four pneumococcal strains had penicillin MICs of 6 mg/mL, 3 strains had penicillin MICs of 8 mg/mL, and 1 strain had a penicillin MIC Downloaded from https://academic.oup.com/cid/article-abstract/31/4/875/374770 by guest on 17 December 2018 of 12 mg/mL. These strains were also resistant to cefotaxime (MIC у0.75 mg/mL), and 1 was susceptible to azithromycin. There were 21 strains of S. pneumoniae with azithromycin MICs 1256 mg/mL. Only 3 of these strains were susceptible to penicillin and cefotaxime.
Three children (2.3%) carried 2 S. pneumoniae isolates at the initial visit, and all 3 were assigned to azithromycin therapy. In 1 child, both strains were azithromycin-susceptible and were eradicated after therapy. The 2 other children carried both a susceptible and a nonsusceptible strain. In both, only the resistant strain was detected after therapy.
Nasopharyngeal carriage after antibiotic treatment. All strains with an increase in penicillin MIC showed changes in PBP banding patterns. Single-band changes at the 1A gene were not associated with changes in MIC.
Influence of additional antimicrobial therapy. In the amoxicillin/clavulanate group, 32 children (50%) received antibiotic therapy between follow-up visits. In this group, 1 child carried penicillin-susceptible S. pneumoniae and 9 carried penicillinnonsusceptible S. pneumoniae at the 2-month follow-up (i.e., after additional antimicrobial therapy). Of the 32 children who did not receive additional antibiotics, 2 carried penicillin-susceptible S. pneumoniae and 2 carried penicillin-nonsusceptible S. pneumoniae at the 2-month follow-up.
In the azithromycin group, 40 children (58%) received antibiotic therapy between follow-up visits; 4 carried penicillinsusceptible S. pneumoniae and 9 carried penicillin-nonsusceptible S. pneumoniae at the 2-month visit. Of the 28 children who did not receive additional antibiotics, 4 carried penicillinsusceptible S. pneumoniae and 8 carried penicillin-nonsusceptible S. pneumoniae.
Analysis by x 2 test failed to demonstrate a significant impact of additional antibacterials on the overall carriage of resistant pneumococcal strains. Clinical response. In the amoxicillin/clavulanate group, 48 children (75%) had a good clinical response to treatment of their AOM, 3 of whom were found to carry penicillin-nonsusceptible S. pneumoniae after therapy. Of the 16 children who had a poor clinical response, 5 carried penicillin-nonsusceptible S. pneumoniae. In the azithromycin group, 44 children (65%) had a good clinical response to therapy; 9 carried penicillinnonsusceptible S. pneumoniae after therapy. Of the 24 children with a poor clinical response, 9 carried penicillin-nonsusceptible S. pneumoniae. There was an association between poor clinical response at the end of therapy and carriage of penicillin-nonsusceptible S. pneumoniae ( ,x 2 test). P p .02 Serogroups and serotypes.
The most common serotypes found in isolates from our patients were 6B, 19F, 14, and 23F. These serotypes accounted for 76% of the pneumococcal strains isolated. Seventy percent of the penicillin-intermediate and penicillin-resistant strains belonged to serotypes 14, 19F, 6B, and 23F.
Discussion
Management of AOM has become more challenging since the worldwide emergence of antibiotic resistance among otitic pathogens [21, 22] . An increasing proportion of resistant pneumococci isolated from cases of AOM has been reported recently from the United States [23] [24] [25] [26] [27] , France [28] , Israel [29] , Spain [30] , and South Africa [31] .
In the United States, ∼25%-30% of pneumococcal strains are penicillin-nonsusceptible S. pneumoniae. In some areas, such as Atlanta and Dallas [32, 33] , resistance rates as high as 50% have been reported. These strains are frequently multiply drugresistant. In this study, carriage of S. pneumoniae was found in 48% of children. Of these pneumococcal isolates, 56% were resistance to penicillin and 40% to azithromycin. Among penicillin-resistant strains, 85% were also azithromycin-resistant.
The increasing prevalence of b-lactamase-producing H. [34] . In our study population, carriage of H. influenzae was 29%, and of these, 41% were b-lactamase producers. We believe that our study population is representative of many private pediatric practices in the United States, in that about one-half of children attended day care and had received antibiotic therapy in the preceding 6 months. It is therefore not surprising that drug-resistant nasopharyngeal bacteria were prevalent.
Young age, siblings, day care attendance, recent antibiotic use, and winter season have been associated with carriage of penicillin-nonsusceptible S. pneumoniae [35] [36] [37] [38] . In our study, we could demonstrate an association only with having a sibling.
Possibly, as the incidence of infection with resistant pneumococci increases, the strong association of individual factors becomes harder to demonstrate.
In our study, neither selection of coresiding resistant strains nor genetic transformation was demonstrated following antibiotic therapy. Even though we attempted to identify coresiding penicillin-susceptible and -nonsusceptible pneumococcal strains with the use of blood agar plates with and without penicillin, we detected coresiding strains in only 2 children. Even with this technique, we cannot exclude the possibility that resistant and susceptible strains were coresiding in some children and that antibiotic therapy did select for resistant, less dominant strains. Transformation of genetic material was also not demonstrated, because the strains isolated at the follow-up visits either were similar or showed multiple differences from streptococci recovered at the time of enrollment.
Although we did observe selection for azithromycin-resistant strains in 2 instances, we were unable to demonstrate that amoxicillin therapy selects for coresiding resistant strains or encourages genetic transformation. Such mechanisms may be uncommon and may be only partly responsible for the development and spread of antibiotic resistance. It is more likely that frequent repeated antibiotic exposure in a population that is at high risk for pneumococcal carriage markedly reduces the pool of susceptible strains, allowing greater opportunity for resistant strains to multiply and spread among children.
Amoxicillin/clavulanate eradicated or suppressed all of the penicillin-susceptible strains, 75% of strains with intermediate penicillin resistance, and only 40% of penicillin-resistant pneumococcal strains after therapy. This suggests that concentrations of amoxicillin in nasopharyngeal secretions were ∼1 mg/ mL. Azithromycin cleared two-thirds of strains susceptible to azithromycin but none of the strains of S. pneumoniae that were nonsusceptible to azithromycin, which suggests that azithromycin concentrations in nasopharyngeal secretions are small. Other authors have found similar results [39, 40] .
In our study, we used susceptibility testing, serotyping, and molecular typing to investigate the ecological impact of antibiotic treatment for AOM on the nasopharyngeal carriage of S. pneumoniae. Molecular methods are more discriminating than susceptibility testing and serotyping in distinguishing differences among S. pneumoniae. At the end of treatment, we found that the 2 antibiotics evaluated differed in their impact on the carriage of S. pneumoniae and H. influenzae. Patients treated with amoxicillin/clavulanate were less likely to carry S. pneumoniae, but if they did, the strain carried was more likely to be resistant to penicillin G. At the end of treatment with azithromycin, a patient is more likely to remain a carrier of S. pneumoniae. In only one-third of these patients, however, was this pathogen susceptible to azithromycin. Amoxicillin/clavulanate was also more effective in decreasing levels of colonization of H. influenzae in our study population.
